Low dose radiotherapy
Sponsors
Allina Health System, Montefiore Medical Center, Juravinski Cancer Center, Valentina Garibotto, Philippe Meyer
Conditions
Alzheimer DiseaseAmyloid CardiomyopathyCOVIDCOVID 19 PNEUMONIACOVID-19COVID-19 PneumoniaColorectal CancerCovid19
Phase 1
Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients
CompletedNCT03812549
Start: 2019-01-18End: 2022-07-08Updated: 2025-03-04
Low Dose Radiotherapy in COVID-19 Pneumonia
NCT04390412
Start: 2020-05-04End: 2020-12-31Updated: 2020-11-10
Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.
RecruitingNCT05615142
Start: 2021-12-15End: 2026-12-31Target: 9Updated: 2024-04-17
Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors
RecruitingNCT06349837
Start: 2024-04-18End: 2026-11-30Target: 24Updated: 2025-12-17
Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma
CompletedNCT06494189
Start: 2024-07-31End: 2025-04-10Updated: 2025-12-29
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
RecruitingNCT06848465
Start: 2025-02-28End: 2027-11-30Target: 9Updated: 2026-04-03
Phase 2
Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC
TerminatedNCT02254681
Start: 2014-09-30End: 2016-09-30Updated: 2018-10-03
Whole-lung low dose radiation therapy (LDRT) in the treatment of severe COVID-19 pneumonia
Active, not recruitingPACTR202009769021840
Start: 2020-09-15Target: 20Updated: 2026-01-27
Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy
WithdrawnNCT06331585
Start: 2024-03-18End: 2026-03-18Updated: 2024-04-25
Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
RecruitingNCT06610734
Start: 2024-12-23End: 2028-12-01Target: 202Updated: 2026-02-09
Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC
WithdrawnNCT06804850
Start: 2025-01-20End: 2026-06-30Updated: 2025-11-19
A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.
RecruitingNCT07040956
Start: 2025-06-28End: 2026-07-01Target: 98Updated: 2025-12-29
Unknown Phase
Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa
TerminatedNCT03040804
Start: 2017-03-01End: 2020-12-21Updated: 2021-11-01
Low Dose Hemi-body Radiation For Recurrent Prostate Cancer
CompletedNCT03196778
Start: 2017-09-25End: 2022-07-18Updated: 2022-08-10
Effect of Low Dose Radiotherapy on Brain Amyloidosis in the Treatment of Alzheimer's Disease
Active, not recruitingNCT03352258
Start: 2017-11-17End: 2027-12-30Updated: 2025-01-09
Effect of Radiotherapy on ATTR Cardiac Amyloidosis : a Proof of Concept Study
RecruitingNCT03397810
Start: 2019-03-15End: 2026-02-28Target: 36Updated: 2021-05-11
Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia
CompletedNCT04534790
Start: 2020-07-24End: 2021-01-08Updated: 2021-02-09
Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia
CompletedNCT04572412
Start: 2020-11-25End: 2022-06-30Updated: 2022-11-10
Low-Dose Radiation Therapy to Lungs in Moderate COVID-19 Pneumonitis: A Case-Control Pilot Study
NCT04904783
Start: 2021-06-01End: 2021-12-31Target: 20Updated: 2021-07-27
Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial
RecruitingNCT06887829
Start: 2025-06-04End: 2026-06-29Target: 128Updated: 2025-06-22